BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

規制と法律 · 2009/10/21 分で読めます

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Novel Use and Method of Rapamycin To Treat Toxic Shock

ローカル自動翻訳 · 情報源の原言語

概要

Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/231,348 entitled "Novel Use and Method of Rapamycin to Treat Toxic Shock," filed August 5, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

情報源の原言語: Federal Register — All Documents原文の発表を開く →

関連インサイト

ビジネスインサイト →